Association of platelet activation markers with cancer-associated venous thromboembolism

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas

(2014) J. Thaler et al.   NEURO-ONCOLOGY

Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty

(2013) David R. Anderson et al.   ANNALS OF INTERNAL MEDICINE

Biomarkers for prediction of venous thromboembolism in cancer

(2013) I. Pabinger et al.   BLOOD

Platelets in cancer and thrombosis

(2013) J. Riedl et al.   Hamostaseologie

Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer

(2013) Alexandra Kaider et al.   THROMBOSIS AND HAEMOSTASIS

Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role

(2012) J. Huang et al.   BLOOD

Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers

(2012) Eui Jin Suh et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

(2012) Marie-Luise von Brühl et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

(2012) Timothy A. Brighton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin for Preventing the Recurrence of Venous Thromboembolism

(2012) Cecilia Becattini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biomarkers of platelet activation in acute coronary syndromes

(2012) Patrizia Ferroni et al.   THROMBOSIS AND HAEMOSTASIS

Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis

(2012) Freesia Horsted et al.   PLOS MEDICINE

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

(2011) A. Larocca et al.   BLOOD

Serum Platelet Factor 4 Is an Independent Predictor of Survival and Venous Thromboembolism in Patients with Pancreatic Adenocarcinoma

(2010) K. E. Poruk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes

(2010) P. STARLINGER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet CD40L at the interface of adaptive immunity

(2010) Bennett D. Elzey et al.   THROMBOSIS RESEARCH

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

(2009) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

(2009) R. SIMANEK et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis

(2009) M. Anna Kowalska et al.   THROMBOSIS RESEARCH

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

(2008) C. Ay et al.   BLOOD

Soluble P-selectin as a marker of in vivo platelet activation

(2008) Patrizia Ferroni et al.   CLINICA CHIMICA ACTA